These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8099547

  • 1. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures.
    Jensen PH, Lorand L, Ebbesen P, Gliemann J.
    Eur J Biochem; 1993 May 15; 214(1):141-6. PubMed ID: 8099547
    [Abstract] [Full Text] [Related]

  • 2. A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking.
    Jensen PH, Schüler E, Woodrow G, Richardson M, Goss N, Højrup P, Petersen TE, Rasmussen LK.
    J Biol Chem; 1994 May 27; 269(21):15394-8. PubMed ID: 7910824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators.
    Barsigian C, Stern AM, Martinez J.
    J Biol Chem; 1991 Nov 25; 266(33):22501-9. PubMed ID: 1682320
    [Abstract] [Full Text] [Related]

  • 6. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY, Liu YX, Liu K, Byrne S, Ny T, Feng Q, Ockleford CD.
    J Anat; 1999 Feb 25; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase.
    Borth W, Chang V, Bishop P, Harpel PC.
    J Biol Chem; 1991 Sep 25; 266(27):18149-53. PubMed ID: 1680857
    [Abstract] [Full Text] [Related]

  • 8. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE, Dobson JV, Greenberg CS.
    Biochim Biophys Acta; 1986 Aug 15; 872(3):261-8. PubMed ID: 2873839
    [Abstract] [Full Text] [Related]

  • 9. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin.
    Ritchie H, Robbie LA, Kinghorn S, Exley R, Booth NA.
    Thromb Haemost; 1999 Jan 15; 81(1):96-103. PubMed ID: 10348718
    [Abstract] [Full Text] [Related]

  • 10. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H, Lawrie LC, Crombie PW, Mosesson MW, Booth NA.
    J Biol Chem; 2000 Aug 11; 275(32):24915-20. PubMed ID: 10816585
    [Abstract] [Full Text] [Related]

  • 11. Vitronectin is a substrate for transglutaminases.
    Sane DC, Moser TL, Pippen AM, Parker CJ, Achyuthan KE, Greenberg CS.
    Biochem Biophys Res Commun; 1988 Nov 30; 157(1):115-20. PubMed ID: 2461707
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: in vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1.
    Oji V, Oji ME, Adamini N, Walker T, Aufenvenne K, Raghunath M, Traupe H.
    Br J Dermatol; 2006 May 30; 154(5):860-7. PubMed ID: 16634887
    [Abstract] [Full Text] [Related]

  • 13. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P, Montuori N, Rossi G.
    Eur J Biochem; 1995 Oct 15; 233(2):514-9. PubMed ID: 7588796
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.
    Mikus P, Urano T, Liljeström P, Ny T.
    Eur J Biochem; 1993 Dec 15; 218(3):1071-82. PubMed ID: 7506655
    [Abstract] [Full Text] [Related]

  • 15. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.
    Placenta; 2000 Dec 15; 21(2-3):184-93. PubMed ID: 10736241
    [Abstract] [Full Text] [Related]

  • 16. C1 inhibitor cross-linking by tissue transglutaminase.
    Hauert J, Patston PA, Schapira M.
    J Biol Chem; 2000 May 12; 275(19):14558-62. PubMed ID: 10799541
    [Abstract] [Full Text] [Related]

  • 17. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.
    Dickinson JL, Norris BJ, Jensen PH, Antalis TM.
    Cell Death Differ; 1998 Feb 12; 5(2):163-71. PubMed ID: 10200461
    [Abstract] [Full Text] [Related]

  • 18. Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes.
    Jensen PH, Nykjaer A, Andreasen PA, Lund LR, Astedt B, Lecander I, Gliemann J.
    Biochim Biophys Acta; 1989 Nov 17; 986(1):135-40. PubMed ID: 2819091
    [Abstract] [Full Text] [Related]

  • 19. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM, Fesüs L, Kopeć M.
    Biochim Biophys Acta; 1980 Dec 04; 616(2):167-78. PubMed ID: 6111338
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J, Schaefer B, Bechtel MJ, Kramer MD.
    Exp Cell Res; 1996 Feb 25; 223(1):91-101. PubMed ID: 8635500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.